JP Morgan downgrades this market darling amid the corona sell-off

The sudden rebound in the ASX 200 from a bear market may prove to be an opportunity to take profit on this highly popular ASX stocks. Here's what you need to know.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Was this the shortest bear market in the history of the ASX?

The market tumbled this morning, taking its peak-to-trough drop to over 20% in the last three weeks. But the market made a stunning comeback into the green ahead of the market close.

The S&P/ASX 200 (Index:^AXJO) (ASX:XJO) index is up 1.3% at the time of writing. Assuming it closes at this level, it would no longer fit the definition of a bear market, which requires a drop of 20% or more.

Is the worst over?

But it isn't all good news. The rebound may be fleeting and there's still a big risk of the market falling back into bear territory.

Some experts also believe investors should be selling into any market rally as the risk of a global recession sparked by COVID-19 will continue to pressure equities.

One stock that could be a target for profit taking is market darling Macquarie Group Ltd (ASX: MQG) after JP Morgan downgraded the investment back to "neutral" from "overweight".

Outperform to underperform

The broker noted that Macquarie was outperforming its peers, including big bank stocks like National Bank of Australia Ltd. (ASX: NAB) and Westpac Banking Corp (ASX: WBC), and fund managers like Magellan Financial Group Ltd (ASX: MFG).

"Unusually for a market correction, MQG has performed in line with the market over the last two weeks and outperformed most of what we would consider to be its peers and comparable companies," said JP Morgan.

"While, in our view, MQG is a more diverse business than in previous downturns and equity investments are a smaller percentage of the balance sheet, we don't think MQG will remain 'low beta' if the current downturn continues and its PER [price-earnings ratio] is starting from reasonably full levels."

Earnings risk

What's more, the broker thinks Macquarie will disappoint from an earnings perspective. While there's every chance that Macquarie will beat profit guidance for FY20 (management is tipping profit to be slightly down), JP Morgan thinks its FY21 guidance will not live up to lofty consensus expectations.

"Prior to the recent COVID-19 breakout we had believed that MQG's FY20 earnings guidance was increasingly conservative given a strong 1H20 result, supportive 3Q20 conditions, and continued AUD depreciation," explained JP Morgan.

"But we see risk that uncertainty on the economic and market backdrop will see it deliver tepid guidance for FY21 at the FY20 result in May."

The broker is now forecasting flat net profit for Macquarie in the next financial year. It had pencilled in a 4% increase before.

JP Morgan lowered its price target on the stock to $132 from $149 a share.

Motley Fool contributor Brendon Lau owns shares of Macquarie Group Limited and Westpac Banking. The Motley Fool Australia owns shares of and has recommended Macquarie Group Limited. The Motley Fool Australia owns shares of National Australia Bank Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Share Gainers

Why BHP, Catalyst Metals, Mesoblast, and Pilbara Minerals shares are shooting higher

These shares are ending the week with a bang. But why?

Read more »

Disappointed man with his head on his hand looking at a falling share price his a laptop.
Share Fallers

Why 29Metals, Atlas Arteria, DroneShield, and Yancoal shares are falling today

Let's see why these shares are ending the week in the red.

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

The Mesoblast share price just rocketed 38%! Here's why

ASX investors just sent the Mesoblast share price up 38%. But why?

Read more »

Stock market chart in green with a rising arrow symbolising a rising share price.
Record Highs

Big ASX 200 news! Market hits 8,700-point record high

It's a historic day for the ASX.

Read more »

Miner with thumbs up at mine
Broker Notes

Up 55% this year, does Macquarie rate Gold Road Resources shares a buy, hold or sell?

Does this strong performing gold miner have more room to run?

Read more »

Two happy woman on a couch looking at a tablet.
Opinions

Why I'm excited to see the results of these ASX 200 shares

These stocks could reveal very interesting insights.

Read more »

couple having a happy discussion with a banker
Healthcare Shares

Expert: 4 ASX healthcare stocks to buy ahead of reporting season

Could these ASX healthcare stocks be good additions to your portfolio?

Read more »

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Broker Notes

Morgans names 3 ASX stocks to buy

The broker is feeling very positive on the investment opportunities here.

Read more »